Structure Therapeutics Inc.
GPCR
$23.74
$0.090.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -122.53M | -110.55M | -100.44M | -97.68M | -89.62M |
| Total Depreciation and Amortization | 996.00K | 819.00K | 626.00K | 468.00K | 316.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.93M | 1.61M | 1.78M | 484.00K | 2.85M |
| Change in Net Operating Assets | 2.96M | 6.22M | -4.73M | 3.47M | 6.97M |
| Cash from Operations | -116.64M | -101.90M | -102.76M | -93.26M | -79.49M |
| Capital Expenditure | -1.29M | -2.43M | -2.57M | -2.33M | -2.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -357.62M | -570.46M | -351.15M | -215.58M | -266.18M |
| Cash from Investing | -358.91M | -572.89M | -353.71M | -217.91M | -268.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 517.06M | 816.56M | 816.64M | 301.52M | 473.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.80M | -20.28M | -19.13M | -19.02M | -21.57M |
| Cash from Financing | 515.26M | 796.28M | 797.51M | 282.51M | 451.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.72M | 121.49M | 341.04M | -28.66M | 103.70M |